NAIC

Plan benefit design, prescription drugs, and race

Plan benefit design, prescription drugs, and race

Carl Schmid presents to NAIC Special Committee on Race & Insurance on how insurance benefit design impacts prescription drug access for racial and ethnic communities and suggestions for overcoming access barriers by reducing utilization management measures, lowering cost-sharing, offering standardized plans, and enforcing ACA non-discrimination policies.

read more
Copay Accumulators, State Bans & IRS Issues

Copay Accumulators, State Bans & IRS Issues

HIV+Hep’s Carl Schmid’s presentation before the NAIC Regulatory Framework Task Force on the value of copay assistance for Rx, state laws that ensure copay assistance counts, and ways to mitigate any potential conflicts with those state laws with IRS/Health Savings Account issues.

read more

Pin It on Pinterest